JAMES A MACLENNAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES A MACLENNAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES A MACLENNAN. JAMES A MACLENNAN is Chief Financial Officer in THERAGENICS CORP ($TGX) and Sr. VP-CFO & Controller in Noble Corp plc ($NE).
Latest Insider Trading Transactions of JAMES A MACLENNAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 02 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Option Exercise | D | 0.00 | 8,339 | 0 | 0 | |
| Feb 02 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Option Exercise | A | 0.00 | 260,456 | 0 | 260,456 | |
| Feb 02 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Option Exercise | A | 0.00 | 111,475 | 0 | 111,475 | |
| Feb 02 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Payment of Exercise | F | 7.40 | 2,240 | 16,565 | 158,090 | 160.3 K to 158.1 K (-1.40 %) |
| Feb 02 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Grant | A | 0.00 | 8,339 | 0 | 160,330 | 152 K to 160.3 K (+5.49 %) |
| Feb 01 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Option Exercise | D | 0.00 | 18,118 | 0 | 36,237 | |
| Feb 01 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Option Exercise | D | 0.00 | 11,961 | 0 | 11,962 | |
| Feb 01 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Option Exercise | D | 0.00 | 50,030 | 0 | 0 | |
| Feb 01 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Payment of Exercise | F | 7.63 | 4,890 | 37,286 | 151,991 | 156.9 K to 152 K (-3.12 %) |
| Feb 01 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Grant | A | 0.00 | 18,118 | 0 | 156,881 | 138.8 K to 156.9 K (+13.06 %) |
| Feb 01 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Payment of Exercise | F | 7.63 | 3,299 | 25,155 | 138,763 | 142.1 K to 138.8 K (-2.32 %) |
| Feb 01 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Grant | A | 0.00 | 11,961 | 0 | 142,062 | 130.1 K to 142.1 K (+9.19 %) |
| Feb 01 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Payment of Exercise | F | 7.75 | 8,009 | 62,070 | 130,101 | 138.1 K to 130.1 K (-5.80 %) |
| Feb 01 2016 | NE | Noble Corp plc | MACLENNAN JAMES A | Sr. VP-CFO & Contro ... | Grant | A | 0.00 | 28,181 | 0 | 138,110 | 109.9 K to 138.1 K (+25.64 %) |
| Feb 10 2005 | TGX | THERAGENICS CORP | MACLENNAN JAMES A | Chief Financial Off ... | Grant | A | 0.00 | 2,850 | 0 | 53,779 | 50.9 K to 53.8 K (+5.60 %) |
| Feb 10 2005 | TGX | THERAGENICS CORP | MACLENNAN JAMES A | Chief Financial Off ... | Grant | A | 0.00 | 2,850 | 0 | 53,779 | 50.9 K to 53.8 K (+5.60 %) |
| Aug 20 2004 | TGX | THERAGENICS CORP | MACLENNAN JAMES A | Chief Financial Off ... | Grant | A | 0.00 | 2,850 | 0 | 38,846 | 36 K to 38.8 K (+7.92 %) |
| Aug 20 2004 | TGX | THERAGENICS CORP | MACLENNAN JAMES A | Chief Financial Off ... | Grant | A | 0.00 | 2,850 | 0 | 38,846 | 36 K to 38.8 K (+7.92 %) |
| Aug 12 2004 | TGX | THERAGENICS CORP | MACLENNAN JAMES A | Chief Financial Off ... | Grant | A | 3.90 | 10,000 | 39,000 | 46,880 | 36.9 K to 46.9 K (+27.11 %) |
Page: 1